Insights into the Reactivity of Gold–Dithiocarbamato Anticancer Agents toward Model Biomolecules by Using Multinuclear NMR Spectroscopy
- 3 September 2013
- journal article
- research article
- Published by Wiley in Chemistry – A European Journal
- Vol. 19 (40) , 13428-13436
Abstract
Some gold(III)–dithiocarbamato derivatives of either single amino acids or oligopeptides have shown promise as potential anticancer agents, but their capability to interact with biologically relevant macromolecules is still poorly understood. We investigated the affinity of the representative complex [AuIIIBr2(dtc‐Sar‐OCH3)] (dtc: dithiocarbamate; Sar: sarcosine (N‐methylglycine)) with selected model molecules for histidine‐, methionine‐, and cysteine‐rich proteins (that is, 1‐methylimidazole, dimethylsulfide, and N‐acetyl‐L‐cysteine, respectively). In particular, detailed mono‐ and multinuclear NMR studies, in combination with multiple 13C/15N enrichments, allowed interactions to be followed over time and indicated somewhat unexpected reaction pathways. Whereas dimethylsulfide proved to be unreactive, a sudden multistep redox reaction occurred in the presence of the other potential sulfur donor, N‐acetyl‐L‐cysteine (confirmed if glutathione was used instead). On the other hand, 1‐methylimidazole underwent an unprecedented acid–base reaction with the gold(III) complex, rather than the expected coordination to the metal center by replacing, for instance, a bromide. Our results are discussed herein and compared with the data available in the literature on related complexes; our findings confirm that the peculiar reactivity of gold(III)–dithiocarbamato complexes can lead to novel reaction pathways and, therefore, to new cytotoxic mechanisms in cancer cells.Keywords
This publication has 46 references indexed in Scilit:
- Chemotherapeutic induction of mitochondrial oxidative stress activates GSK-3α/β and Bax, leading to permeability transition pore opening and tumor cell deathCell Death & Disease, 2012
- Antitumor activity of gold(III)‐dithiocarbamato derivatives on prostate cancer cells and xenograftsInternational Journal of Cancer, 2010
- The status of platinum anticancer drugs in the clinic and in clinical trialsDalton Transactions, 2010
- Current applications and future potential for bioinorganic chemistry in the development of anticancer drugsDrug Discovery Today, 2009
- Transition metal complexes of short multihistidine peptidesDalton Transactions, 2009
- Glutathionato-S-Gold(III) complexes formed as intermediates in the reduction of auricyanide by glutathioneJournal of Inorganic Biochemistry, 2008
- Antiproliferative and apoptotic effects of two new gold(III) methylsarcosinedithiocarbamate derivatives on human acute myeloid leukemia cells in vitroAnti-Cancer Drugs, 2007
- Gold Dithiocarbamate Derivatives as Potential Antineoplastic Agents: Design, Spectroscopic Properties, and in Vitro Antitumor ActivityInorganic Chemistry, 2005
- WinGXsuite for small-molecule single-crystal crystallographyJournal of Applied Crystallography, 1999
- Structure of 1,8-bis(dimethylamino)naphthalene hydrobromide dihydrateJournal of Chemical Crystallography, 1983